Granules Jeedimetla facility located at Hyderabad, Telangana, India has successfully completed the US FDA’s surveillance inspection with zero observations, the company announced through an exchange filing. The inspection was completed between June 19 and June 23.
Jeedimetla facility manufactures Active Pharmaceutical Ingredients (API) and Pharmaceutical Formulation Intermediates (PFIs).
Granules shares
The shares of Granules on Friday closed at Rs 286.95, down by 0.35 per cent.
Chhangur Baba’s Rs 60-Crore Dirty Money Trail: Acquired Assets In Mumbai, Vasai via Proxies, ED Probe Reveals
Mumbai News: Irla Residents Warn of Protests Over BMC’s Alleged Plan To Demolish Legal Crucifix
Maharashtra Govt Grants Full Tuition And Exam Fee Waiver To Orphan Students In Higher Education
Mumbai: With Bags, Tiffins And Bright Eyes, SoBo Parents Become Students For A Day To Experience School Through Their Children’s Eyes
